21. Juni 2024 – The European Union has introduced a new version of the Clinical Trials Information System (CTIS), implementing revised transparency rules that eliminate the deferral mechanism previously used to protect confidential trial data. This update enables earlier access to information on over 4,000 authorized trials, with approximately 500 new trials added monthly, including those transitioning from the Clinical Trials Directive. The CTIS enhancements aim to improve accessibility for patients, healthcare professionals, and stakeholders, promoting transparency while maintaining confidentiality as per regulations overseen by the European Commission and managed by the European Medicines Agency (EMA).

For more information, see here.